La Jolla Institute for Immunology

What we can learn from SARS

Researchers comb through hundreds of studies to find clues to beating COVID-19
22-May-2020 12:55 PM EDT, by La Jolla Institute for Immunology

Newswise — LA JOLLA, CA—Seventeen years ago, another viral outbreak was in the news. People wore masks, many were nervous to fly. This outbreak, known as SARS, was caused by a type of coronavirus we now call SARS-CoV-1. The difference was that SARS-CoV-1 was controlled and the virus is all but extinct. The newspaper headlines became a distant memory.

But research on coronaviruses continued in labs around the world, and those studies have helped inform the fast-paced COVID-19 research today.

“We need solutions right now,” says Sara Landeras-Bueno, Ph.D., a postdoctoral researcher at La Jolla Institute (LJI). “But it’s so challenging to stay up-to-date on all the publications.”

Indeed, researchers today are publishing 50 to 100 studies a day on COVID-19, and not all the studies have been subject to rigorous peer review. To help researchers understand the mountain of new coronavirus data, Ying-Ting Wang, Ph.D., Sara Landeras-Bueno Ph.D., Jose Angel Regla-Nava, Ph.D., and colleagues recently led a review comparing findings from more than 200 COVID-19 studies with immunological and virological findings in previous SARS research. Their summary, published this week in the online edition of Trends in Microbiology, emphasizes the need for better animal models and structural studies for COVID-19 treatment and vaccine development.

Regla-Nava, who has experience studying SARS and MERS, explains that the viruses that cause SARS and COVID-19 are 79 percent identical. This means we could potentially learn a lot from SARS about how long immunity might last against the novel coronavirus, called SARS-CoV-2. Several recent studies have shown that a person exposed to SARS can still have SARS-fighting antibodies for many years after infection. But the actual number of antibodies really declines after two years.

This could mean that vaccines and natural immunity against SARS-CoV-2 may only provide protection for a few years. 

The researchers also looked at structural studies showing where antibodies can attack these viruses. Both viruses have “spike” proteins that protrude from the virus and are exposed to the human immune system.

Can SARS antibodies also attack these spike proteins on the novel coronavirus? “Although most of the proteins in these viruses are similar, they are not exactly the same,” says Landeras-Bueno. “So it was not easy to find antibodies that could neutralize both.”

Regla-Nava believes we’ll have to tweak current mouse models in the effort to develop vaccines that can elicit truly neutralizing antibodies. “It’s really important to have good animal models for these studies,” he says.

In the meantime, the LJI team is hard at work as part of the LJI Coronavirus Task Force. Wang says it remains critical to try to stay up-to-date with breakthroughs worldwide and summarize those findings in a useful way.

“This is what we can do for now to help the scientific community,” says Wang. 

This review was supported by the Ley, Shresta and Saphire labs at LJI. The work was funded by the Bill and Melinda Gates Foundation grant # INV-006133.

Full citation: Ying-Ting Wang, Sara Landeras-Bueno, Li-En Hsieh, Yutaka Terada, Kenneth Kim, Klaus Ley, Sujan Shresta, Erica Ollmann Saphire and  Jose Angel Regla-Nava. Spiking Pandemic Potential: Structural and Immunological aspects of SARS-CoV-2. Trends in Microbiology, 2020. Doi:

Read the review: Spiking Pandemic Potential: Structural and Immunological aspects of SARS-CoV-2

About La Jolla Institute for Immunology

The La Jolla Institute for Immunology is dedicated to understanding the intricacies and power of the immune system so that we may apply that knowledge to promote human health and prevent a wide range of diseases. Since its founding in 1988 as an independent, nonprofit research organization, the Institute has made numerous advances leading toward its goal: life without disease.



Filters close

Showing results

1120 of 2486
Released: 7-Jul-2020 1:40 PM EDT
COVID-related discrimination disproportionately impacts racial minorities, study shows
University of Southern California (USC)

Discrimination against people thought to be infected with coronavirus was experienced by a rising number of United States residents, particularly racial minorities, in the early stages of the COVID-19 pandemic, according to a new study from the USC Dornsife College of Letters, Arts and Sciences.

Newswise: 236726_web.jpg
Released: 7-Jul-2020 1:10 PM EDT
A chemical cocktail of air pollution in Beijing, China during COVID-19 outbreak
Institute of Atmospheric Physics, Chinese Academy of Sciences

The novel coronavirus disease (COVID-19) spreads rapidly around the world, and has limited people's outdoor activities substantially.

Released: 7-Jul-2020 12:50 PM EDT
Remdesivir can save more lives where ICUs are overwhelmed
Boston University School of Medicine

Amid news that the United States has bought up virtually the entire global supply of remdesivir, a new Boston University School of Public Health (BUSPH) study outlines how the drug could save lives in countries with less hospital capacity, such as South Africa, where COVID-19 is beginning to overwhelm intensive care units (ICUs).

Newswise: Cedars-Sinai Named Age-Friendly Health System
Released: 7-Jul-2020 12:40 PM EDT
Cedars-Sinai Named Age-Friendly Health System

Shortly after COVID-19 was declared a pandemic, more than 450 older adults learned their weekly exercise classes offered through the Cedars-Sinai Geriatrics Program were on hold. But under the quick-thinking direction of geriatrician Allison Moser Mays, MD, the program pivoted, creating a way for seniors to access live classes over Zoom from the comfort of their homes. The online format has proved especially popular.

Newswise: WashU Expert: Eviction moratoriums are incomplete solution
Released: 7-Jul-2020 11:55 AM EDT
WashU Expert: Eviction moratoriums are incomplete solution
Washington University in St. Louis

Millions of tenants are at risk of eviction as protections in the CARES Act are set to expire. While the U.S. Congress and Senate are proposing plans to extend the federal moratorium on evictions, a finance expert at Washington University in St. Louis warns that is just one piece of the puzzle.

Released: 7-Jul-2020 11:40 AM EDT
Beaumont researchers develop COVID-19 test that can detect virus in saliva, blood or urine in 45 minutes
Beaumont Health

Rapid test for COVID-19 can help contain the virus and contribute to a successful reopening of the economy

Released: 7-Jul-2020 11:15 AM EDT
Study: surgical delay associated with increased risk in some gastrointestinal malignancies
Beth Israel Deaconess Medical Center

Early in the COVID-19 pandemic, widespread cancellations of electively-scheduled or “non-emergency” operations were implemented to free up hospital beds and conserve protective equipment for health care workers. For some conditions, including cancer, timely surgery is critical for patients’ survival. In a new study published in the Journal of Gastrointestinal Surgery, a team of investigators at Beth Israel Deaconess Medical Center (BIDMC) examined the effects of delaying surgery for gastrointestinal cancers.

Newswise: GettyImages%20Sickle%20Cell.jpg
Released: 7-Jul-2020 9:35 AM EDT
COVID-19: What you should know if you have sickle cell disease
LifeBridge Health

If you have sickle cell disease, you are at higher risk than the general population for severe complications from COVID-19.

Newswise: sharon-mccutcheon-8lnbXtxFGZw-unsplash-1024x683.jpg
Released: 6-Jul-2020 4:50 PM EDT
COVID-19 demonstrates why wealth matters
Washington University in St. Louis

While COVID-19 has impacted all individuals, the impact has not been equal. In a new national Socioeconomic Impact of COVID-19 survey, the Social Policy Institute at Washington University in St. Louis found that liquid assets increased the likelihood that an individual could practice social distancing. However, Black individuals were least likely to afford social distancing.

Newswise: University of Miami Launches COVID-19 Heart Program
Released: 6-Jul-2020 2:50 PM EDT
University of Miami Launches COVID-19 Heart Program
University of Miami Health System, Miller School of Medicine

A new COVID-19 Heart Program developed by cardiologists with the University of Miami Miller School of Medicine is addressing the varied heart issues stemming from the pandemic with comprehensive screenings and evaluations in a safe clinical setting. It also incorporates the latest findings from UM cardiology researchers studying how the coronavirus can affect the heart and its surrounding tissues.

Showing results

1120 of 2486